Breast cancer: Early detection

Radiologic-Pathologic Correlations from Head to Toe: Understanding the Manifestations of Disease

Volumn , Issue , 2005, Pages 767-784

  Schreer, Ingrid ^a   Lüttges, Jutta ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66749121769     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-26664-X_35     Document Type: Chapter

References (14)

1. Ellis IO,Galea M,Broughton N (1992) Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 20 :479-489
2. Rosen PP, Saigo PE, Braun DW (1989) Pathologic prognostic factors in stage I and stage II breast carcinoma: a study of 655 patients with a median follow-up of 18 years. J Clin Oncol 7 : 1239-1251
3. Sickles EA (1997) Management of lesions appearing probably benign at mammography. In: Friedrich M, Sickles EA (ed) Radiological diagnosis of breast diseases. Springer, Berlin Heidelberg New York, pp 167-172
4. Stavros AT, Thickmann D, Rapp CL et al (1995) Solid breast nodules: use of sonography to determine between benign and malignant nodules. Radiology 196 :123-134
5. WHO Classifications of tumours (2003) Tumours of the breast and female genitale organs. IARC Press, Lyon
6. Tab L (1997) In: Silverstein MJ (ed) Ductal carcinoma in situ of the breast. Lippincott, Williams and Wilkins, Philadelphia
7. Silverstein MJ, Lagios MD, Groshen S,Waisman JR, Lewinsky BS, Matino S, Gamagami P, Colbum WJ (1999) The influence of margin with on local control of ductal carcinoma in situ of the breast.New Engl J Med 340 :1455-1461
8. Page DL, Anderson TJ (1987) Diagnostic histopathology of the breast.New York Churchill Livingston
9. Tavassoli FA, Norris HF (1990) A comparison of long-term follow-up for atypical hyperplasia and intraductal hyperplasia of the breast. Cancer 65 :518
10. Page DL,Dupont WD, Rogers L (1988) Ductal involvement by cells of a typical lobular hyperplasia: a long-term follow-up study of cancer risk.Human Pathol 19 :201-207
11. Dupont WD, Page DL (1989) Relative risk of breast cancer varies with time and diagnosis of a typical hyperplasia. Human Pathol 20 :723-725
12. Fisher B, Dignam J,Wolmark,Wickerham DL, Fisher ER,Mamounas E, Smith R, Begociv M, Dimitrov NV, Margolese RG, Kardinal CG, Kavanah MT, Fehrenbacher I, Oishi RH (1999) Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast an bowel project B-24 randomized controlled trial. Lancet 353 :1993-2000
13. Wickerham DL, Costantino J, Fisher B, Kavanah M,Wolmark N (1999) Average annual rates of invasive an noninvasive breast cancer by history of LCIS and atypical hyperplasia for participants in the BCPT. Proc.ASCO 327
14. Cauley J, Krueger K, Eckert S,Muchmore D, Taylor Y, Scott T (1999) Raloxifen reduces breast cancer risk in postmenopausal women with osteoporosis, 40-month data from the MORE trial (Abstract #328). Proc ASCO